Some of Rutgers' top health researchers are calling for a change in our approach to developing COVID-19 vaccines, and vaccines to fight future pandemics, to incorporate both conventional and challenge ...
Pheast Therapeutics is using a platform-based approach to scaling manufacturing for its anti-CD24 checkpoint inhibitor, PHST001. By compressing the chemistry, manufacturing, and control (CMC) steps ...
Joshua Kaufman, MD, medical director of Behavioral Health and Medical Integration at Capital District Physicians' Health Plan, outlines the progression of treatment approaches for comorbid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback